Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ: 011040)
South Korea
· Delayed Price · Currency is KRW 6,220.00
-20.00 (-0.32%)
Dec 20, 2024, 2:13 PM KST
Kyung Dong Pharmaceutical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 189,188 | 162,674 | 182,718 | 177,611 | 173,828 | 176,500 | Upgrade
|
| Other Revenue | - | - | -0 | - | - | -0 | Upgrade
|
| Revenue | 189,188 | 162,674 | 182,718 | 177,611 | 173,828 | 176,500 | Upgrade
|
| Revenue Growth (YoY) | 14.17% | -10.97% | 2.88% | 2.18% | -1.51% | -1.57% | Upgrade
|
| Cost of Revenue | 80,166 | 73,331 | 86,808 | 79,528 | 74,560 | 72,360 | Upgrade
|
| Gross Profit | 109,022 | 89,344 | 95,910 | 98,082 | 99,268 | 104,140 | Upgrade
|
| Selling, General & Admin | 95,860 | 86,471 | 70,602 | 68,447 | 67,295 | 67,470 | Upgrade
|
| Research & Development | 14,680 | 13,827 | 12,618 | 10,537 | 10,063 | 8,918 | Upgrade
|
| Other Operating Expenses | 12,384 | 12,469 | 2,434 | 1,603 | 1,388 | 1,301 | Upgrade
|
| Operating Expenses | 124,300 | 114,298 | 87,598 | 82,324 | 79,563 | 79,588 | Upgrade
|
| Operating Income | -15,279 | -24,955 | 8,312 | 15,758 | 19,705 | 24,552 | Upgrade
|
| Interest Expense | -1,540 | -1,596 | -867.87 | -65.82 | -1,234 | -465.6 | Upgrade
|
| Interest & Investment Income | 2,264 | 3,170 | 2,702 | 2,610 | 2,769 | 2,325 | Upgrade
|
| Earnings From Equity Investments | -84.05 | 3,083 | 11,387 | -155.57 | -100.42 | 8,888 | Upgrade
|
| Currency Exchange Gain (Loss) | -53.36 | -5.73 | -40.15 | 161.08 | -377.02 | 19.15 | Upgrade
|
| Other Non Operating Income (Expenses) | -424.51 | -410.62 | -1,701 | -736.18 | -1,350 | -188.46 | Upgrade
|
| EBT Excluding Unusual Items | -15,116 | -20,714 | 19,792 | 17,572 | 19,412 | 35,131 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1,742 | 2,149 | -1,709 | 786.97 | -97.44 | 249.84 | Upgrade
|
| Gain (Loss) on Sale of Assets | 63.56 | 61.03 | -142.27 | 73.23 | 24.37 | 17.89 | Upgrade
|
| Asset Writedown | -10 | - | - | - | - | -454.1 | Upgrade
|
| Pretax Income | -13,320 | -18,503 | 17,941 | 18,432 | 19,339 | 34,945 | Upgrade
|
| Income Tax Expense | 3,727 | 2,227 | 5,828 | 5,806 | 6,467 | 12,114 | Upgrade
|
| Earnings From Continuing Operations | -17,047 | -20,730 | 12,113 | 12,627 | 12,873 | 22,831 | Upgrade
|
| Minority Interest in Earnings | 42.72 | 22.77 | 48.4 | 45.13 | -413.43 | -2,705 | Upgrade
|
| Net Income | -17,005 | -20,708 | 12,161 | 12,672 | 12,459 | 20,126 | Upgrade
|
| Net Income to Common | -17,005 | -20,708 | 12,161 | 12,672 | 12,459 | 20,126 | Upgrade
|
| Net Income Growth | - | - | -4.03% | 1.71% | -38.09% | 283.92% | Upgrade
|
| Shares Outstanding (Basic) | 27 | 27 | 27 | 28 | 25 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | 27 | 27 | 27 | 28 | 25 | 24 | Upgrade
|
| Shares Change (YoY) | -0.39% | -0.27% | -1.14% | 12.18% | 3.62% | 0.20% | Upgrade
|
| EPS (Basic) | -629.14 | -763.17 | 446.96 | 460.42 | 507.81 | 849.97 | Upgrade
|
| EPS (Diluted) | -629.14 | -763.17 | 446.96 | 460.42 | 507.81 | 849.97 | Upgrade
|
| EPS Growth | - | - | -2.92% | -9.33% | -40.26% | 283.14% | Upgrade
|
| Free Cash Flow | -19,318 | -6,322 | -11,649 | 8,496 | -11,475 | -4,836 | Upgrade
|
| Free Cash Flow Per Share | -714.72 | -232.98 | -428.12 | 308.70 | -467.69 | -204.22 | Upgrade
|
| Dividend Per Share | 400.000 | 400.000 | 400.000 | 500.000 | 500.000 | 400.000 | Upgrade
|
| Dividend Growth | 0% | 0% | -20.00% | 0% | 25.00% | 33.33% | Upgrade
|
| Gross Margin | 57.63% | 54.92% | 52.49% | 55.22% | 57.11% | 59.00% | Upgrade
|
| Operating Margin | -8.08% | -15.34% | 4.55% | 8.87% | 11.34% | 13.91% | Upgrade
|
| Profit Margin | -8.99% | -12.73% | 6.66% | 7.13% | 7.17% | 11.40% | Upgrade
|
| Free Cash Flow Margin | -10.21% | -3.89% | -6.38% | 4.78% | -6.60% | -2.74% | Upgrade
|
| EBITDA | -9,871 | -19,106 | 15,016 | 22,770 | 26,479 | 31,519 | Upgrade
|
| EBITDA Margin | -5.22% | -11.74% | 8.22% | 12.82% | 15.23% | 17.86% | Upgrade
|
| D&A For EBITDA | 5,408 | 5,849 | 6,704 | 7,011 | 6,774 | 6,966 | Upgrade
|
| EBIT | -15,279 | -24,955 | 8,312 | 15,758 | 19,705 | 24,552 | Upgrade
|
| EBIT Margin | -8.08% | -15.34% | 4.55% | 8.87% | 11.34% | 13.91% | Upgrade
|
| Effective Tax Rate | - | - | 32.49% | 31.50% | 33.44% | 34.67% | Upgrade
|
| Advertising Expenses | - | 5,248 | 10,315 | 9,603 | 10,510 | 11,118 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.